Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment

M Del Re, A Addeo, A Passaro, I Petrini, Ron van Schaik, R Danesi

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

Research programs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{3526dd24bc584d7a993a42d4de7b3f1d,

title = "Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment",

author = "{Del Re}, M and A Addeo and A Passaro and I Petrini and {van Schaik}, Ron and R Danesi",

year = "2019",

doi = "10.2217/pgs-2019-0150",

language = "Undefined/Unknown",

volume = "20",

pages = "1255--1257",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Future Medicine Ltd.",

number = "18",

}

TY - JOUR

T1 - Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment

AU - Del Re, M

AU - Addeo, A

AU - Passaro, A

AU - Petrini, I

AU - van Schaik, Ron

AU - Danesi, R

PY - 2019

Y1 - 2019

U2 - 10.2217/pgs-2019-0150

DO - 10.2217/pgs-2019-0150

M3 - Article

C2 - 31829835

SN - 1462-2416

VL - 20

SP - 1255

EP - 1257

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 18

ER -